153 related articles for article (PubMed ID: 6314624)
1. [Curative radiotherapy in stage C prostatic carcinoma. Experiences with radiotherapy-endocrine treatment].
Klosterhalfen H; Becker H; Köllermann MW; Altenähr E
Urologe A; 1983 Sep; 22 Suppl():360-6. PubMed ID: 6314624
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy of prostatic carcinoma].
Fuse H; Katayama T; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1991 Aug; 37(8):801-8. PubMed ID: 1659778
[TBL] [Abstract][Full Text] [Related]
3. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
Granfors T; Modig H; Damber JE; Tomic R
J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
[TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy of localized prostatic carcinoma].
Gez E; Netzer-Horowitz Y; Waiman E; Rubinov R; Cohen Y; Kuten A
Harefuah; 1997 Dec; 133(12):593-6, 664. PubMed ID: 9451865
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
6. [Prostatic cancer in the young adult].
Sfaxi M; Miladi M; Bacha K; Zermani R; Chebil M; Ayed M
Prog Urol; 2003 Apr; 13(2):313-5. PubMed ID: 12765073
[TBL] [Abstract][Full Text] [Related]
7. Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
Wachter-Gerstner N; Wachter S; Goldner G; Nechvile E; Pötter R
Strahlenther Onkol; 2002 Oct; 178(10):542-7. PubMed ID: 12386785
[TBL] [Abstract][Full Text] [Related]
8. [Update of experience with prostatic cancer].
Nitecki S; Kuten A; Cohen Y
Harefuah; 1993 Mar; 124(5):261-5, 320, 319. PubMed ID: 8495915
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy combined with hormone therapy for prostate cancer.
Tsuya A; Kawai T; Fukushima S; Shida K; Shimazaki J
Strahlentherapie; 1974 Jul; 148(1):24-34. PubMed ID: 4216125
[TBL] [Abstract][Full Text] [Related]
10. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
11. [Brachytherapy results in prostatic cancer].
Prada Gómez PJ; Canteli M; Alonso A; Olay L; Alonso R; Reinerio R; Juan G; Fernández J
Arch Esp Urol; 1999; 52(1):32-8; discussion 38-9. PubMed ID: 10101885
[TBL] [Abstract][Full Text] [Related]
12. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
13. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
[TBL] [Abstract][Full Text] [Related]
15. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy of prostatic cancer: Stanford University experience.
Bagshaw MA
Prog Clin Biol Res; 1984; 153():493-512. PubMed ID: 6382285
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
19. Radical external beam radiation therapy for prostate carcinoma.
Garrett PG; Herman JG; Rawlings GA; Hawkins NV; Gospodarowicz MK; Keen CW; Rider WD
J Can Assoc Radiol; 1984 Jun; 35(2):139-43. PubMed ID: 6480665
[TBL] [Abstract][Full Text] [Related]
20. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features.
Vargas C; Martínez A; Galalae R; Demanes J; Harsolia A; Schour L; Nuernberg N; Gonzalez J
Prostate Cancer Prostatic Dis; 2006; 9(3):245-53. PubMed ID: 16786040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]